The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.32
Bid: 42.22
Ask: 42.28
Change: -0.02 (-0.05%)
Spread: 0.06 (0.142%)
Open: 41.72
High: 42.74
Low: 41.72
Prev. Close: 42.34
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading update

13 Jan 2020 07:00

RNS Number : 5048Z
Assura PLC
13 January 2020
 

13 January 2020

Assura plc

 

Trading Update

For the third quarter ending 31 December 2019

 

Continued strong performance

 

Assura plc ("Assura"), the leading primary care property investor and developer, today announces its Trading Update for the third quarter ending 31 December 2019.

 

Jonathan Murphy, CEO, said:

 

"Assura continued to make strong progress in the third quarter. We expanded our market-leading portfolio with the acquisition of six high-quality assets and completed our third development of the year in Stow-on-the-Wold. We also grew our immediate pipeline of acquisition and development opportunities, reinforcing what was already our strongest in 10 years, to £252 million including 13 developments currently on site."

 

"With the new Government enshrining in law increased funding for the NHS and taking forward the Health Infrastructure Plan, better primary care facilities for patients, staff and services are at the heart of the agenda. In this context, Assura is well positioned to deliver high-quality assets and value for money for the NHS."

 

Building the portfolio

·; Current portfolio of 563 properties.

·; Development completed at Stow-on-the-Wold, taking total to three completed year to date at a total cost of £11.8 million.

·; Currently on site with 13 developments at the period end with a total development cost of £66 million.

·; Six acquisitions completed in the period at a cost of £31.1 million; four disposals made for cash proceeds of £1.0 million.

 

Expanding the pipeline

·; Immediate development pipeline further increased to £90 million, up from £72 million at September 2019.

·; Immediate acquisitions pipeline further increased to £96 million, up from £65 million at September 2019.

·; Total immediate pipeline, including on site developments, worth £252 million, up from £206 million at September 2019.

 

Growing the rent roll

·; Five lease re-gears completed in the quarter taking cumulative year-to-date re-gears to 18. These leases represent £1.7 million of the Group's rent roll, adding a weighted average of 10.2 years WAULT to those 18 leases.

·; Annualised rent roll at £105.8 million taking account of additions, disposals and rent reviews.

 

Robust balance sheet

·; As at 31 December 2019 gross debt stood at £787 million with undrawn facilities of £280 million.

 

As previously announced, the quarterly dividend has been increased to 0.697 pence per share with effect from January 2020. This is equivalent to 2.788 pence per share on an annualised basis.

 

ENDS

 

 

For further information, please contact:

 

Assura plc:

Jayne Cottam, CFO

David Purcell, Head of Financial Reporting

 

Tel: 01925 420 660

 

Finsbury:

Gordon Simpson

James Thompson

 

Tel: 0207 251 3801

 

This announcement contains inside information as defined in Article 7 of the EU Market Abuse Regulation No 596/2014 and has been announced in accordance with the Company's obligations under Article 17 of that Regulation.

 

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 30 September 2019, Assura's property portfolio was valued at £2,039 million.

 

Further information is available at www.assuraplc.com

 

*EPRA is a registered trademark of the European Public Real Estate Association.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFLFERLEIILII
Date   Source Headline
22nd May 20133:49 pmRNSForm 8.5 (EPT/NON-RI)- Replacement
22nd May 201312:41 pmRNSForm 8.3 - Assura Group
22nd May 201312:01 pmPRNForm 8.3 - Assura Group Ltd
22nd May 201311:37 amRNSForm 8.5 (EPT/RI)
22nd May 201310:25 amRNSForm 8.5 (EPT/RI)
22nd May 20139:50 amRNSForm 8.3 - Assura Group Limited
22nd May 20139:30 amRNSForm 8.5 (EPT/NON-RI)
22nd May 20138:49 amRNSForm 8.5 (EPT/NON-RI)
22nd May 20137:00 amBUSForm 8.3 - Assura Group Limited
21st May 20132:42 pmRNSForm 8.3 - Assura Group Limited
21st May 20139:42 amRNSForm 8.5 (EPT/NON-RI)
21st May 20139:16 amRNSForm 8.5 (EPT/RI)
21st May 20138:56 amRNSForm 8.5 (EPT/NON-RI)
20th May 20133:16 pmRNSForm 8.3 - MedicX Fund Limited
20th May 20132:57 pmRNSForm 8.3 - [Assura Group Limited]
20th May 20132:31 pmRNSForm 8.3 - Assura Group Ltd
20th May 201312:56 pmRNSForm 8.3 - MedicX Fund Limited
20th May 201312:17 pmBUSForm 8.3 - Assura Group Limited
20th May 201311:52 amRNSForm 8.5 (EPT/NON-RI)
20th May 201311:38 amRNSForm 8.5 (EPT/NON-RI)
20th May 201311:13 amRNSForm 8.5 (EPT/RI)
20th May 201310:54 amRNSForm 8.3 - Assura Group
20th May 20137:00 amRNSPossible offer update and Rule 2.10 disclosure
17th May 20136:24 pmRNSStatement re Possible Offer
17th May 20133:54 pmRNSAnnouncement re unsolicited approach
2nd Apr 20137:00 amRNSConfirmation of REIT status
13th Mar 201311:25 amRNSDirector/PDMR Shareholding
15th Feb 20133:20 pmRNSResults of EGM
31st Jan 20137:00 amRNSInterim Management Statement
29th Jan 20134:51 pmRNSNotification of Grant of Share Award to PDMR
28th Jan 20134:49 pmRNSNotice of Extraordinary General Meeting
8th Jan 20137:00 amRNSSale of Former Head Office Building
21st Dec 201211:38 amRNSConfirmation of Quarterly Interim Dividend
10th Dec 20122:58 pmRNSDirector/PDMR Shareholding
29th Nov 20126:33 pmRNSDirector Shareholding Announcement-Replacement
29th Nov 20124:33 pmRNSTransfer of Shares
28th Nov 20127:00 amRNSAssura Group Limited Interim Results 2012
13th Nov 201212:02 pmRNSAnnouncement of half year results date
28th Sep 20122:45 pmRNSConfirmation of Quarterly Interim Dividend
27th Sep 20129:00 amRNSAppointment of joint corporate broker
25th Sep 201210:00 amRNSAssura Group Transfer of Shares
21st Sep 20122:57 pmRNSHolding in Company - Laxey Partners Limited
18th Sep 20127:00 amRNSAppointment of Finance Director
11th Sep 20123:46 pmRNSResult of AGM
31st Aug 20123:56 pmRNSAnnual Information Update
15th Aug 20127:00 amRNSInterim Management Statement
16th Jul 20124:02 pmRNSChange of Registered Office
13th Jul 201211:16 amRNSDirector/PDMR Shareholding
2nd Jul 20124:12 pmRNSDirector/PDMR Shareholding
26th Jun 20127:00 amRNSPreliminary results for year ended 31 March 2012

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.